Skip to main content
. 2016 Sep 12;59(3):210–216.

Fig. 5.

Fig. 5.

Survival curves for patients with stage II–III gastric cancer and postoperative intra-abdominal complication by drugs used for adjuvant chemotherapy. Prognosis did not significantly differ between patients who took UFT and those who took S-1 (P = 0.24). S-1, tegafur-gimeracil-oteracil; UFT, tegafur-uracil.